Universitaetsmedizin Goettingen — Göttingen

Public research footprint of Universitaetsmedizin Goettingen, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET… · Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Prostate Cancer · Mild Cognitive Impairment Due to Alzheimer's Disease

Recently updated registry entries

NCT07007065 — Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… (Recruiting)
NCT07105488 — A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis (Active Not Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitaetsmedizin Goettingen?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.